Thursday, July 28, 2016


Aviesan-Inserm invited to participate in the 1st Scientific Meeting of the African academy for sciences and arts (July 19th- 21st, 2016)


Almost two hundreds African scientists were invited to present their research programmes dealing with health, environment and agriculture. Aviesan-Inserm took this opportunity to speak of the new technologies developed in the industrial countries to help elderlies and incapacitated persons to stay home longer. The presentation highlighted the use of these technologies but also the ethical tensions they raised (the loss of privacy for example). During the debate with the audience, it turns out that these technologies will soon respond to the challenge of the growing aging population leaving now in the big urban centers of the middle income countries.

Tuesday, December 29, 2015



TRUST project starts

Creating and enhancing TRUSTworthy, responsible and equitable partnerships in international research”


Co-funded by the European Commission, TRUST main objective is to reduce the risk of exporting non ethical practices, that-is-to-say ‘ethics dumping’, in all the fields of research to low and middle income countries (LMICs). As a Coordination and Support Action of Horizon 2020, this is not a research project. TRUST is thus aimed to catalyse a global collaborative effort to improve adherence to high ethical standards in research in LMICs. The implementation of TRUST just starts, and will end at the end of 2018.

Context:
Globalization of research activities is raising the risk of developing research sensitive ethical issues being conducted by European organisations outside the EU without proper compliance structures and follow‐up. This phenomenon has highlighted gaps in global research ethics governance. Several governance frameworks and standards to guide research activities have been initiated, but there are disparate and lacking a guiding vision. That is why TRUST will use existing frameworks and tools in order to reinforce and enhance them.

Project overview:
‘Ethics dumping’ means both purposeful exploitation of third country research participants/resources as well as exploitation based on insufficient ethics awareness. In this respect, the project is built on an interdisciplinary collaboration between multi-level actors (e.g. ethics bodies, policy makers, civil society organisations, funding organisations, industry and academic scholars), an essential aspect to get a global view on the ethics issue, to receive wide responses, and to target a large public.

During three years, the TRUST international consortium and its networks will collaborate to create and start implementing three tools preventing from ethics dumping: a Global Code of conduct, designed for funders and researchers especially, containing major principles of equitable research partnerships; on-line Fair Research Contracts protecting vulnerable populations involved in research and ensuring fair benefits-sharing; and a Compliance and ethics follow-up designed for a wide use, for all stakeholders.

Activities are based on case studies involving local structures in countries where the research takes place and impacts population. In addition to internal production of case studies, a bottom-up call for competition with 2,000€ to win has been launched in order to collect original case studies (deadline March the 2nd, 2016), for instance misuse of health technologies. English and French application form is available at the following link: http://www.progressproject.eu/news/2208-case-competition-reducing-the-risk-of-exporting-unethical-research-practices/

To reinforce the guiding vision of TRUST, a funder and industry platform of dialogue is been designed to co-ordinate and support activities of the TRUST partners. Indeed funders are powerful agents in achieving high ethical standards globally, having already a legal requirement to comply with their financial instruments.

The TRUST project is a stimulus to then allow the international community to take over. Global adherence to high ethical standards and the sustainability of the impact of TRUST’s mission will be ensured through the establishment of a global network by the development of a collaboration platform, creating an international forum for exchange of information and views, and establishing confidence between stakeholders.

Thursday, July 30, 2015

Aviesan-Inserm is present in the proposal winner of the H2020 call 'Reducing the risk of exporting non ethical practices to third countries'

This 18-month proposal named 'Creating and enhancing TRUSTworthy, responsible and equitable partnerships in international research' (TRUST), aims at proposing the analysis of research conducted in low and middle income countries which can pose an ethical risk. Drafting recommendations to anticipate or avoid them, is also required by the tender. This project coordinated by the University of Lancachire (UK) brings together 13 partners from Europe (UK, France, Switzerland), Asia (India) and Africa (Kenya, South Africa). The partnership includes academic (including Inserm), NGOs (including Action contre la faim), the European institutions (EDCTP) and an international organization (UNESCO). Finally, the consortium will benefit from the advice of a broad panel of academic experts and also representatives of institutions such as the Wellcome Trust and the Council of Europe.

Sunday, November 2, 2014

"Vietnam’s quest for new solutions to address the challenge of TB detection & control" (Ho Chi Minh City, 10-11 November 2014)
A meeting co-organised by PHUSA BIOCHEM and BÊNH VIÊN PHAM NGOC THACH is to be held soon in  Vietnam. The objective of this meeting is to assess the medical reality and TB needs in Vietnam and to bridge current TB medical practices with technical innovation. In this context, Phusa Biochem’ s R&D activities related to the development of a TB diagnostic prototype will be presented. The meeting is expected to constitute the basis for a successful alliance between the public and the private sector for needs-driven innovation for health. Information available at http://phusabiochem.com/hoinghi/kittb/?page_id=15.

Monday, July 28, 2014

EDCTP 2 is back with new opportunities!

 

The European and Developing Countries Clinical Trials Partnership (EDCTP) was created in 2003 as a European response to the global health crisis caused by the three main poverty-related diseases of HIV/AIDS, tuberculosis and malaria. EDCTP aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria, with a focus on phase II and III clinical trials in sub-Saharan Africa.

On 6 May 2014, the Council of the European Union (EU) approved the participation of the EU in the second phase of the EDCTP programme (EDCTP2). With an EU contribution of € 683 million for the 10-year programme period and additional contributions from Participating States and third parties, EDCTP2 will continue to support the clinical development of new or improved diagnostics, drugs, vaccines and microbicides against HIV/AIDS, tuberculosis, and malaria.However, EDCTP2 will now support research on neglected infectious diseases (NIDs).

EDCTP2 will continue to promote and support:

   * Multicentre projects that combine clinical trials, capacity building and networking
   *  Capacity development for clinical trials and clinical research in developing countries
    * Fellowships
    * Closer collaboration with industry, like-minded organisations, funders of global health research and development cooperation agencies.

The geographical focus of EDCTP2’s activities will remain on sub-Saharan Africa, although collaborative research with other developing countries outside sub-Saharan Africa could be envisioned when possible and desirable.

The first call 'Diagnostic tools for poverty-related diseases' has just been published at http://www.edctp.org/calls-and-grants/calls-for-proposals/diagnostic-tools-for-poverty-related-diseases/


As a result of the possibility to support research on neglected infectious diseases, the project anticipated with DNDi (see blog April 25th, 2013 ) will be revitalized and a meeting with DNDi is planned soon in Geneva.

Also, given the possibility to extend now collaboration with other developing countries out of Africa, the potential evaluation of a low-cost PCR-based TB diag tool designed by CTGen (see blog August, 2013) in Africa,  is under consideration.

 


Friday, January 17, 2014

Meeting La Paillasse



We received the visit of a member of the French association La Paillaisse which defines itself as a  “biohackerspace” and which belongs to the international movement DIY BIO (Do-It-Yourself Biologist).  The aim is to build biological projects made available to all in term of direct participation and in term of sharing results and technologies. The design of materials such as UV- transilluminator, cell  centrifuge… are some of the projects in progress with the ultimate goal to permit every one, everywhere to do the same (no licencing, publishing of the whole procedures).We discussed the possibilities to forward this information to our partners, NGOs and scientists working in LMICs. 
You may contact La Paillasse at adrienclavairoly@hotmail.com

Monday, September 16, 2013

Meeting CTGen

We recently met Dr NGO Nam in Aviesan premises, the owner of CTGen
a company based in California which provides easy-to-use DNA synthesis supports. Dr NGO also developed a sister company in Vietnam CTGEN-PSA which aims at facilitating the use of PCR in LMICs. Dr NGO will make all efforts to attend the AEC Biomedical Innovation Forum 2013, the international conference and exhibition on Health Technology for Development co-organised by Aviesan and the National Innovation Agency of Thailand scheduled 14 - 16 November 2013 in Bangkok 
http://www.nia.or.th/biomed2013/

August, 2013